Homebiotech

biotech

Stay Connected
- Advertisement -spot_img
Latest Articles

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

Memento Medicines, Inc., a privately-held biotech company developing biologic therapies for retinal diseases, has complete a $93m Series A financing round co-led by Forbion,...